Effective next Sunday (March 27), David Pyott, the chairman and chief executive at Allergan, is going to add his former title of president again. He held that position from 1998 to 2006. He's picking up the job from Michael Ball, who is leaving the company to become CEO of Hospira, ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.